サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1459783

ホルモン性避妊薬市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年

Hormonal Contraceptive Market (Method: Oral Contraceptives, Transdermal Patches, Injectable Contraceptives, Intrauterine Contraceptives, and Vaginal Rings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031

出版日
ページ情報
英文 161 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ホルモン性避妊薬市場：世界の産業分析、規模、シェア、成長、動向、予測、2023-2031年
出版日: 2024年02月27日
発行: Transparency Market Research
ページ情報: 英文 161 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン性避妊薬市場- 調査範囲

TMRの調査レポート「ホルモン性避妊薬の世界市場」は、2023年から2031年までの予測期間における市場の指標について貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界のホルモン性避妊薬市場の収益と予測を提供します。また、2023年から2031年までの世界のホルモン性避妊薬市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、ホルモン性避妊薬市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照しました。

市場スナップショット
2022年の市場価値 218億米ドル
2031年の市場価値 338億米ドル
CAGR 5%

本レポートでは、世界のホルモン性避妊薬市場の競合情勢について掘り下げています。世界のホルモン性避妊薬市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートで紹介されている世界のホルモン性避妊薬市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：ホルモン性避妊薬市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • ホルモン性避妊薬市場分析と予測、2017年～2031年

第5章 主要洞察

  • パイプライン分析
  • 主要技術/ブランド分析
  • 主要M&A
  • COVID-19パンデミックの業界への影響

第6章 ホルモン性避妊薬市場分析と予測：方法別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：方法別、2017年～2031年
    • 経口避妊薬
    • 経皮吸収パッチ
    • 注射避妊薬
    • 子宮内避妊薬
    • 膣リング
  • 市場魅力度分析：方法別

第7章 ホルモン性避妊薬市場分析と予測：ホルモン別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：ホルモン別、2017年～2031年
    • 黄体ホルモンのみ
    • 複合ホルモン剤
  • 市場魅力度分析：ホルモン別

第8章 ホルモン性避妊薬市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：流通チャネル別、2017年～2031年
    • ドラッグストア
    • 婦人科/不妊治療クリニック
    • eコマース
    • その他
  • 市場魅力度分析：流通チャネル別

第9章 ホルモン性避妊薬市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017年～2031年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米のホルモン性避妊薬市場分析と予測

第11章 欧州のホルモン性避妊薬市場分析と予測

第12章 アジア太平洋のホルモン性避妊薬市場分析と予測

第13章 ラテンアメリカのホルモン性避妊薬市場分析と予測

第14章 中東・アフリカのホルモン性避妊薬市場分析と予測

第15章 競合情勢

  • 市場競合：競合マトリックス（ティア別・企業規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • AbbVie, Inc.
    • Afaxys, Inc.
    • Bayer AG
    • Agile Therapeutics
    • Merck & Co., Inc.
    • Piramal Enterprises Ltd.
    • Pfizer Inc.
    • HLL Lifecare Limited
図表

List of Tables

  • Table 01: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 02: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 03: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 07: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 08: North America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 11: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 12: Europe Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 15: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 16: Asia Pacific Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 19: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 20: Latin America Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Method, 2017-2031
  • Table 23: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Hormones, 2017-2031
  • Table 24: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Hormonal Contraceptive Market Size (US$ Mn) and Distribution (%), by Region, 2017-2031
  • Figure 02: Hormonal Contraceptive Market Revenue (US$ Mn), by Method, 2022
  • Figure 03: Hormonal Contraceptive Market Value Share, by Method, 2022
  • Figure 04: Hormonal Contraceptive Market Revenue (US$ Mn), by Hormones, 2022
  • Figure 05: Hormonal Contraceptive Market Value Share, by Hormones, 2022
  • Figure 06: Hormonal Contraceptive Market Revenue (US$ Mn), by Distribution Channel, 2022
  • Figure 07: Hormonal Contraceptive Market Value Share, by Distribution Channel, 2022
  • Figure 08: Hormonal Contraceptive Market Value Share, by Region, 2022
  • Figure 09: Hormonal Contraceptive Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 10: Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 11: Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 12: Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 13: Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 14: Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 15: Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 16: Hormonal Contraceptive Market Value Share Analysis, by Region, 2017-2031
  • Figure 17: Hormonal Contraceptive Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 18: North America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Hormonal Contraceptive Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 20: North America Hormonal Contraceptive Market Value Share Analysis, by Country, 2017-2031
  • Figure 21: North America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 22: North America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 23: North America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 24: North America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 25: North America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 26:North America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 27: Europe Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 29: Europe Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 30: Europe Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 31: Europe Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 32: Europe Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 33: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 34: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 35: Europe Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 36: Asia Pacific Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 38: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 39: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 40: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 41: Asia Pacific Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 42: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 43: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 44: Asia Pacific Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 45: Latin America Hormonal Contraceptive Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 47: Latin America Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 48: Latin America Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 49: Latin America Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 50: Latin America Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 51: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 52: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 53: Latin America Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 54: Middle East & Africa Hormonal Contraceptive Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 56: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Country/Sub-region, 2017-2031
  • Figure 57: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Method, 2017-2031
  • Figure 58: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Hormones, 2017-2031
  • Figure 59: Middle East & Africa Hormonal Contraceptive Market Value Share Analysis, by Distribution Channel, 2017-2031
  • Figure 60: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Method, 2017-2031
  • Figure 61: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Hormones, 2017-2031
  • Figure 62: Middle East & Africa Hormonal Contraceptive Market Attractiveness Analysis, by Distribution Channel, 2017-2031
目次
Product Code: TMRGL49380

Hormonal Contraceptive Market - Scope of Report

TMR's report on the global hormonal contraceptives market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global hormonal contraceptives market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormonal contraceptives market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hormonal contraceptives market.

Market Snapshot
Market Value in 2022US$ 21.8 Bn
Market Value in 2031US$ 33.8 Bn
CAGR5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormonal contraceptives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormonal contraceptives market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormonal contraceptives market.

The report delves into the competitive landscape of the global hormonal contraceptives market. Key players operating in the global hormonal contraceptives market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormonal contraceptives market profiled in this report.

Key Questions Answered in Global hormonal contraceptives Market Report:

  • What is the sales/revenue generated by hormonal contraceptives across all regions during the forecast period?
  • What are the opportunities in the global hormonal contraceptives market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hormonal Contraceptive Market - Research Objectives and Research Approach

The comprehensive report on the global hormonal contraceptives market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormonal contraceptives market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormonal contraceptives market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Hormonal Contraceptive Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Technology Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Hormonal Contraceptive Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Technology/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Hormonal Contraceptive Market Analysis and Forecast, by Method

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Method, 2017-2031
    • 6.3.1. Oral Contraceptives
    • 6.3.2. Transdermal Patches
    • 6.3.3. Injectable Contraceptives
    • 6.3.4. Intrauterine Contraceptives
    • 6.3.5. Vaginal Rings
  • 6.4. Market Attractiveness Analysis, by Method

7. Hormonal Contraceptive Market Analysis and Forecast, by Hormones

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Hormones, 2017-2031
    • 7.3.1. Progestin Only
    • 7.3.2. Combined Hormones
  • 7.4. Market Attractiveness Analysis, by Hormones

8. Hormonal Contraceptive Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Drug Stores
    • 8.3.2. Gynecology/Fertility Clinics
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness Analysis, by Hormones

9. Hormonal Contraceptive Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Hormonal Contraceptive Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Method, 2017-2031
    • 10.3.1. Oral Contraceptives
    • 10.3.2. Transdermal Patches
    • 10.3.3. Injectable Contraceptives
    • 10.3.4. Intrauterine Contraceptives
    • 10.3.5. Vaginal Rings
  • 10.4. Market Value Forecast, by Hormones, 2017-2031
    • 10.4.1. Progestin Only
    • 10.4.2. Combined Hormones
  • 10.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.5.1. Drug Stores
    • 10.5.2. Gynecology/Fertility Clinics
    • 10.5.3. E-commerce
    • 10.5.4. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Method
    • 10.7.2. By Hormones
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Hormonal Contraceptive Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Method, 2017-2031
    • 11.3.1. Oral Contraceptives
    • 11.3.2. Transdermal Patches
    • 11.3.3. Injectable Contraceptives
    • 11.3.4. Intrauterine Contraceptives
    • 11.3.5. Vaginal Rings
  • 11.4. Market Value Forecast, by Hormones, 2017-2031
    • 11.4.1. Progestin Only
    • 11.4.2. Combined Hormones
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Drug Stores
    • 11.5.2. Gynecology/Fertility Clinics
    • 11.5.3. E-commerce
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Method
    • 11.7.2. By Hormones
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Hormonal Contraceptive Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Method, 2017-2031
    • 12.3.1. Oral Contraceptives
    • 12.3.2. Transdermal Patches
    • 12.3.3. Injectable Contraceptives
    • 12.3.4. Intrauterine Contraceptives
    • 12.3.5. Vaginal Rings
  • 12.4. Market Value Forecast, by Hormones, 2017-2031
    • 12.4.1. Progestin Only
    • 12.4.2. Combined Hormones
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Drug Stores
    • 12.5.2. Gynecology/Fertility Clinics
    • 12.5.3. E-commerce
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Method,
    • 12.7.2. By Hormones
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Hormonal Contraceptive Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Method, 2017-2031
    • 13.3.1. Oral Contraceptives
    • 13.3.2. Transdermal Patches
    • 13.3.3. Injectable Contraceptives
    • 13.3.4. Intrauterine Contraceptives
    • 13.3.5. Vaginal Rings
  • 13.4. Market Value Forecast, by Hormones, 2017-2031
    • 13.4.1. Progestin Only
    • 13.4.2. Combined Hormones
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Drug Stores
    • 13.5.2. Gynecology/Fertility Clinics
    • 13.5.3. E-commerce
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Method,
    • 13.7.2. By Hormones
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Hormonal Contraceptive Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Method, 2017-2031
    • 14.3.1. Oral Contraceptives
    • 14.3.2. Transdermal Patches
    • 14.3.3. Injectable Contraceptives
    • 14.3.4. Intrauterine Contraceptives
    • 14.3.5. Vaginal Rings
  • 14.4. Market Value Forecast, by Hormones, 2017-2031
    • 14.4.1. Progestin Only
    • 14.4.2. Combined Hormones
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Drug Stores
    • 14.5.2. Gynecology/Fertility Clinics
    • 14.5.3. E-commerce
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Method,
    • 14.7.2. By Hormones
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. AbbVie, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Technology, Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Afaxys, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Technology, Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Bayer AG
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Technology, Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Agile Therapeutics
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Technology, Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Merck & Co., Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Technology, Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Piramal Enterprises Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Technology, Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Pfizer Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Technology, Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. HLL Lifecare Limited
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Technology, Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview